Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U. S. experience Meeting Abstract


Authors: Smyth, E. C.; Enzinger, P. C.; Li, J.; Vincitore, M.; Lacy, J.; El-Rayes, B. F.; Kunz, P. L.; Ford, J. M.; Robinson, E.; Kelsen, D. P.; Shah, M. A.
Abstract Title: Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U. S. experience
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880300466
DOI: 10.1200/jco.2011.29.15_suppl.4056
PROVIDER: wos
Notes: Meeting Abstract: 4056 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Elizabeth Catherine Smyth
    21 Smyth
  2. Manish Shah
    177 Shah
  3. David P Kelsen
    537 Kelsen